# IRX Therapeutics, Inc. — Form D

IRX Therapeutics, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-14. The offering totals $18.0M, of which $15.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-03-14
- Form: D
- Accession: 0001411920-14-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.0M
- Amount sold: $15.1M
- Remaining: $2.9M
- Investors: 104
- Date of first sale: 2014-02-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-213624

## Issuer

- Name: IRX Therapeutics, Inc.
- CIK: 0001411920
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 654 MADISON AVENUE, New York, NY, 10065
- Phone: 212-582-1199

## Officers, directors & promoters (21)

| Name | Role | Location |
| --- | --- | --- |
| David H Deming | Director | King of Prussia, PA |
| Jeffrey Hwang | Executive Officer | New York, NY |
| Frank J Loverro | Director | New York, NY |
| John W Hadden II | Director | Sparta, NJ |
| John W Hadden II | Executive Officer | Sparta, NJ |
| Charles R Cherington | Director | Houston, TX |
| George P Denny III | Director | Houston, TX |
| Mark W Leuchtenberger | Director | New York, NY |
| Mark W Leuchtenberger | Executive Officer | New York, NY |
| John D Halpern | Director | New York, NY |
| Ferid D Murad | Director | New York, NY |
| Lawrence M Wolf | Director | New York, NY |
| Edmund W Truell | Director | New York, NY |
| Zygmund P Roth | Executive Officer | New York, NY |
| Monil W Shah | Executive Officer | New York, NY |
| Curtis P Robb | Executive Officer | New York, NY |
| John T Spitznagel | Director | New York, NY |
| John W Hadden | Director | New York, NY |
| Ferid W Murad | Director | New York, NY |
| Howard H Stevenson | Director | New York, NY |
| Jeffrey Hwuang | Executive Officer | New York, NY |

## Other filings by this issuer (9)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-08-29](https://search.stillhousedata.com/formd/0001411920-17-000002) | D/A | $33.2M | $33.2M |
| [2017-01-12](https://search.stillhousedata.com/formd/0001411920-17-000001) | D | $13.2M | $13.2M |
| [2016-11-09](https://search.stillhousedata.com/formd/0001411920-16-000005) | D | $8.0M | $6.4M |
| [2016-05-13](https://search.stillhousedata.com/formd/0001411920-16-000003) | D | $15.0M | $2.0M |
| [2015-08-17](https://search.stillhousedata.com/formd/0001411920-15-000002) | D/A | $40.6M | $40.6M |
| [2015-01-15](https://search.stillhousedata.com/formd/0001411920-15-000001) | D | $31.6M | $31.6M |
| [2012-05-30](https://search.stillhousedata.com/formd/0001411920-12-000003) | D | $1.5M | $1.5M |
| [2010-06-11](https://search.stillhousedata.com/formd/0001411920-10-000003) | D | — | $8.0M |
| [2010-01-11](https://search.stillhousedata.com/formd/0001411920-10-000001) | D | $6.0M | $2.2M |

## More

- [CIK 1411920 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1411920&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001411920-14-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.